Allogene Therapeutics (ALLO) traded flat 0 % during a 24 hours period ending at 04:20 PM Central Europe on Monday 26th. One Allogene Therapeutics stock can currently be bought for about USD 1.26 on popular exchanges. Current supply of Allogene Therapeutics stocks is 345.5 mn. Allogene Therapeutics has a current market capitalization of USD 431.9 mn and approximately USD 10.5 mn worth of Allogene Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Allogene Therapeutics has traded -25.15 % down. Simple moving average of last 200 days is at USD 1.99. The highest price of past 52 weeks was recorded at USD 4.46 on 04/13/2026. 52 weeks low was at USD 1.04 on 11/07/2025.

Here is how related stocks have performed in the past 24 hours:

  • York Water (YORW) traded up 0.41 % and now trades at USD 31.86. Current market capitalisation for York Water is USD 516.4 mn. York Water has a current price to earnings ratio of 19.7.

  • Lightpath (LPTH) traded up 3.85 % and now trades at USD 7.54. Current market capitalisation for Lightpath is USD 510.6 mn.

  • Choiceone Svcs (COFS) traded up 0.38 % and now trades at USD 34.54. Current market capitalisation for Choiceone Svcs is USD 512.4 mn. Choiceone Svcs has a current price to earnings ratio of 9.45.

  • Orange County (OBT) traded up 0.16 % and now trades at USD 38.91. Current market capitalisation for Orange County is USD 513.7 mn. Current price/earnings ratio for Orange County is 10.75.

  • Bright Minds Biosciences (DRUG.CN) traded up 0.11 % and now trades at CAD 73.26. Current market capitalisation for Bright Minds Biosciences is CAD 722.6 mn.

About Allogene Therapeutics

Allogene Therapeutics, Inc. is a biotechnology company that specializes in developing allogeneic chimeric antigen receptor T-cell therapy for treating blood cancers and solid tumors. This health care-focused organization operates out of its South San Francisco-based facility and primarily serves patients residing in the State of California. You can learn more about their mission and offerings by visiting their website, www.allogene.com , or by trading their stocks on the Nasdaq stock exchange.